MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-BR-26-0062265
Delius Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹19.28 Cr
▲ 7% YoY
Net profit · FY 2024
₹51.12 Lakh
Net margin 2.7%
EBITDA · FY 2024
₹78.22 Lakh
EBITDA margin 4.1%
Authorised capital
₹99 Lakh
Registered with MCA
Paid-up capital
₹65 Lakh
Issued & subscribed
Open charges
₹2 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Delius Pharmaceuticals Private Limited
Data last updated:
Delius Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2014PTC270434. Its GSTIN is 07AAFCD1143H1Z0 (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹99 Lakh and a paid-up capital of ₹65 Lakh. It is led by directors Digvijay Kumar Shrivastawa and Kunal Kumar.
Its last annual general meeting (AGM) was held on 30 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 370 Commercial Building Vegas Mall Dwarka Sector – 14, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.28 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹51.12 Lakh (net margin 2.7%) and EBITDA of ₹78.22 Lakh (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 202% over three years and 63% over five years.
The company is associated with 1 brand: Delius. As per MCA filings, the company has open charges of ₹2 Cr on record. Court records list 46 cases involving the company, including 3 filed by the company and 43 filed against it; 36 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹64 Lakh; the latest was in November 2022. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 3 smaller; the largest is Avlaan Pharmaceutical Private Limited with revenue of ₹19.36 Cr.
Delius Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0062265). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website delius.in.
Company details
CIN U24232DL2014PTC270434
Registration Number 270434
Incorporation Date 14 August 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 October 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-BR-26-0062265
Recognitions & Rankings of Delius Pharmaceuticals
Contact details
Delius Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is delius.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 370 Commercial Building Vegas Mall Dwarka Sector – 14, New Delhi, Delhi, India – 110078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Delius Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Delius Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Delius Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Delius Pharmaceuticals Private Limited, buy the company report.
Financials of Delius Pharmaceuticals Private Limited
FY 2025 filings availableDelius Pharmaceuticals Private Limited reported revenue of ₹19.28 Cr (up 7% YoY) for FY 2024.
Revenue · FY 2024
₹19.28 Cr ▲ 7%
Net profit · FY 2024
₹51.12 Lakh margin 2.7%
EBITDA · FY 2024
₹78.22 Lakh margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 202%
5 years · compounded
▲ 63%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 95%
5 years · compounded
▲ 53%
Revenue has grown at a compounded annual rate (CAGR) of 63% over five years, including 7% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Delius Pharmaceuticals Private Limited, buy the company report.
Board of directors of Delius Pharmaceuticals Private Limited
Delius Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Digvijay Kumar Shrivastawa | Director | 14 Aug 2014 | 12 Years 2 Months | Current |
| Kunal Kumar | Director | 31 Jul 2025 | 1 Years 2 Months | Current |
Peer comparison
Delius Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avlaan Pharmaceutical Private Limited | ₹19.36 Cr (FY 2024) | 28.0% | Chennai, Tamil Nadu, India | |||
| Medic Biologicals and Pharmaceuticals Private Limited | ₹19.33 Cr (FY 2025) | 26.0% | Thiruvananthapuram, Kerala, India | |||
| Lxir Medilabs Private Limited | ₹19.32 Cr (FY 2025) | 20.0% | Panchkula, Haryana, India | |||
| Delius Pharmaceuticals Private Limitedthis company | ₹19.28 Cr (FY 2024) | ₹51.12 Lakh | 2.7% | 7.0% | New Delhi, Delhi, India | |
| Anax Lifescience Private Limited | ₹19.25 Cr (FY 2024) | 9.0% | Ahmedabad, Gujarat, India | |||
| Curosis Healthcare Private Limited | ₹19.23 Cr (FY 2024) | 16.0% | Ahmedabad, Gujarat, India | |||
| Elkos Healthcare Private Limited | ₹19.21 Cr (FY 2025) | 10.0% | Shahabad Markanda, Haryana, India |
To see the full peer comparison of Delius Pharmaceuticals Private Limited, buy the company report.
Auditor
Delius Pharmaceuticals Private Limited is audited by SATPRAKASHMONGA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SATPRAKASHMONGA | FY 2023 | 081562 |
Shareholding
The shareholding of Delius Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Delius Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jan 2025 | 101050962 | Others | ₹2 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Delius Pharmaceuticals Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹64 Lakh; the latest was in November 2022.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹64 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2022 | Funding round | ₹64 Lakh | Investors: 2 individuals |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Delius Pharmaceuticals Private Limited has 46 court cases on record: 3 filed by Delius Pharmaceuticals, 43 filed against it. 36 cases are pending and 10 are disposed.
Total cases
46
Filed by the company
3
Filed against the company
43
Pending
36
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 45 | 42 | 36 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 46)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Covalent Laboratories Pvt. Ltd., Rep. by Mr. N. Eswara Rao | Pending |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by M/S Century Pharmaceuticals Limited Its Authorized Signatory Balkrishna Shetty | Pending |
| District court, South West, Delhi | Commercial suit | Filed by the company against M/S Bizcovery Private Limited | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by Diyakaran Enterprises LLP | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Orbit Lifescience Pvt Ltd Through Authorized Representative | Pending |
To see the full case history of Delius Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Delius Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Delius Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 03, 2024.
Active EPFO establishments
1
GST
Delius Pharmaceuticals has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD1143H1Z0 | Delhi | Active | 07 Jul 2022 |
| 10AAFCD1143H2ZC | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Delius Pharmaceuticals Private Limited, buy the company report.
Recent activity
Delius Pharmaceuticals Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Kunal Kumar was appointed as Director on 31 Jul 2025.
AGM
Delius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Oct 2025 as per latest MCA records.
Appointed
Kunal Kumar was appointed as Director.
Filing
Delius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 101050962 was registered on 14 Jan 2025.
Ceased
Sapna Srivastwa ceased to be Additional Director.
Appointed
Sapna Srivastwa was appointed as Director.
Ceased
Ved Prakash ceased to be Director.
Appointed
Digvijay Kumar Shrivastawa was appointed as Director.
Incorporation
14 Aug 2014
Delius Pharmaceuticals Private Limited was registered on 14 Aug 2014 with Roc Delhi & aged 12 years 2 months as per MCA records.
Frequently asked questions
Delius Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 August 2014 (12+ years old) and is registered under CIN U24232DL2014PTC270434.
Delius Pharmaceuticals has 2 current directors:
- Digvijay Kumar Shrivastawa - Director
- Kunal Kumar - Director
The latest financial statements of Delius Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 October 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Delius Pharmaceuticals is 07AAFCD1143H1Z0, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 10AAFCD1143H2ZC (Bihar).
The CIN (Corporate Identification Number) of Delius Pharmaceuticals is U24232DL2014PTC270434. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Delius Pharmaceuticals has 46 court cases on record: 3 filed by the company and 43 filed against it. 36 are pending. Most are in the district courts.
Delius Pharmaceuticals was incorporated on 14 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Delius Pharmaceuticals has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹64 Lakh; the latest was in November 2022.
The peers of Delius Pharmaceuticals by revenue are Avlaan Pharmaceutical Private Limited, Medic Biologicals and Pharmaceuticals Private Limited, Lxir Medilabs Private Limited, Anax Lifescience Private Limited, Curosis Healthcare Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kunal Kumar was appointed as Director on 31 Jul 2025. Sapna Srivastwa ceased to be Additional Director on 30 Sep 2016. Sapna Srivastwa was appointed as Director on 24 Apr 2016. Delius Pharmaceuticals has 5 board changes on record in total.
Yes, Delius Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-BR-26-0062265).